Electrophysiology
Cobalt™ and Crome™ ICD and CRT-D portfolio
Learn about transvenous implantable cardioverter defibrillators (ICDs) used for tachyarrhythmia management.
The Cobalt™ and Crome™ implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy - defibrillator (CRT-D) portfolio is enabled with 40 J energy availability on the first shock and every shock,1 extended longevity, and BlueSync™ technology, allowing for tablet-based programming and app-based remote monitoring to streamline the patient and provider experience.1 Select models include intrinsic antitachycardia pacing (iATP) which is the only automated and smart antitachycardia pacing (ATP) algorithm that provides individualized therapy in real time,2 exclusive algorithms to manage atrial fibrillation (AF), and compatibility with a simplified heart failure risk stratification tool to help meet the needs of physicians and their patients.
Watch our journey.
Watch the video to learn how our new ICD and CRT-D portfolio is delivering innovation to help meet the needs of patients and physicians.
We do not review or control the content of external sites and are not responsible for any interactions or transactions that may occur there. Any product availability and regulatory requirements on the destination site may differ depending on your location. When you continue, the terms of use and privacy statement of the external site will apply.
Product availability and regulatory requirements may differ depending on your location. The destination website is governed by the laws and regulations of the country in which it operates, which may be different from those in your country. When you continue, the terms of use and privacy statement of the destination Medtronic site will apply.